Interleukin-10 induces inhibitory C/EBPβ through STAT-3 and represses HIV-1 transcription in macrophages

American Journal of Respiratory Cell and Molecular Biology

Volumn 33, Issue 4, 2005, Pages 406-411

  Tanaka, Naohiko ^b   Hoshino, Yoshihiko ^b   Gold, Jeffrey ^b   Hoshino, Satomi ^b   Martiniuk, Frank ^b   Kurata, Takeshi ^b   Pine, Richard ^b   Levy, David ^b   Rom, William N ^b   Weiden, Michael ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Infection; Innate immunity; Repression; Transcription factors

Indexed keywords

BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; INTERFERON RECEPTOR; INTERLEUKIN 10; LIPOARABINOMANNAN; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HIV-1; HUMANS; INTERFERONS; INTERLEUKIN-10; MACROPHAGES; MICE; MONOCYTES; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM TUBERCULOSIS;

EID: 26244441377     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0140OC     Document Type: Article

References (36)

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Interm Med 2003;163:1009-1021.
2. Toossi Z. Virological and immnnological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis 2003;188:1146-1155.
3. Hoshino Y, Nakata K, Hoshino S, Honda Y, Tse D, Shioda T, Rom WNm Weiden M. Maximal HIV-I replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cylokines. J Exp Med 2002;195:495-505.
4. Orenstein JM, Fox C, Whal SM. Macrophages as a source of HIV during opportunistic infections. Science 1997;276:1857-1861.
5. Nakala K, Rom W, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M. M. tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997;155:996-1003.
6. Finzi D, Hermankova M, Pierson T, Carruth L, Buck C, Chaisson R, Quinn T, Chadwick K, Margolick J, Brookmeyer R. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278:1295-1300.
7. Tesmer VM, Rajadhyaksha A, Babin J, Bina M. NF IL-6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90:7298-7303.
8. Henderson AJ, Calame KL. CCAAT/enhancer binding protein (OEBP) sites are required for HIV-1 replication in primary macrophages bill not CD4+ T cells. Proc Natl Acad Sci USA 1997;94:8714-8719.
9. Pope RM, Leutz A, Ness SA. C/EBP-Beta regulation of the tumornecrosis-factor-alpha gene. J. Clin Invest 1994;94:1449-1455.
10. K). Zhang Y, Broser M, Rom WN. Activation of the interleukin-6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by NF-IL6 and NF-κ. Proc Natl Acad Sci USA 1994;91:2225-2229.
11. Henderson AJ, Connor RI, Calame KL. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 1996;5:91-101.
12. Zhang Y, Nakata K, Weiden M, Rom W. Mycobacterium tuberculosis enhances HIV-1 replication by transcriptional activation at the long terminal repeal. J. Clin Invest 1995;95:2324-2331.
13. Honda Y, Rogers L, Nakala K, Zhao B, Pine R, Nakai Y, Kurosu K. Rom WN, Weiden M. Type 1 interferon induces inhibitory 16 kDa C/EBP-β repressing the HIV-1 LTR in macrophages: pulmonary tuberculosis alters C/EBP expression enhancing HIV-1 replication. J. Exp Med 1998;188:1255-1265.
14. Descombes P, Schibler U. A liver-enriched transcriptional activator protein. LAP, and a transcriptional inhibitory protein. LIP. are translated from the same mRNA. Cell 1991;67:569-579.
15. An MR, Hsieh CC, Reisner PD, Rabek JP, Scoll SG, Kunninger DT, Papaconstantinou J. Evidence for posttranscriptional regulation of C/EBP-α and C/EBP-β isoform expression during lipopolysaccharide-mediated acute-phase response. Mol Cell Biol 1996;16:2295-23016.
16. Baldwin BR, Timchenko NA, Zahnow CA. Epidermal growth factor receplor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPβ-LIP in mammary epithelial cells. Mol Cell Biol 2004;24:3682-3691.
17. Kim J, Cantwell CA, Johnson PF, Pfarr CM, Williams SC. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J. Biol Chem 2002;277:38037-38044.
18. Henderson AJ, Zou X, Calame K. C/EBP proteins activate transcription from human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol 1995;69:5337-5344.
19. Weiden M, Tanaka N, Qiao Y, Zhao BY, Honda Y, Nakata K, Canova A, Levy DE, Rom WN, Pine R. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and C/EBPβ expression. J. Immunol 2000;165:2028-2039.
20. Hwang S, Herzog PJ, Holland K, Sumarsono S, Tymms MJ, Hamilton JA, Whitty G, Bertoncello I, Kola I. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses Io interferon α and β and alters macrophage responses. Proc Natl Acad Sci USA 1995;92:11284-11288.
21. Durbin J, Hackenmiller R, Simon M, Lew D. Targeted disruption of the mouse Stat-1 gene results in compromised innate immunity to viral disease. Cell 1996;84:443-450.
22. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Bercxovskaya A, Rousset D, Reynes JM, Goldfeld AE. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000;105:1317-1324.
23. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Rohertson S, Wallis RS, Edmoiuls K, Okwera A, Mugerwa R. et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect Dis 1999;180:2069-2073.
24. Othieno C, Hirsch CS, Hamilton BD, Wilkinson K, Ellner JJ, Toossi Z. Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta I and interleukin-10. Infect Immun 1999;67:5730-5735.
25. Bonecini-Almeida MG, Ho JL, Boechal N, Huard RC, Chitale S, Doo H, Gcng JY, Rego L, Lazzarini LCO, Kritski AL. et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TCP-beta receptors I and II in active tuberculosis. Infect Immun 2004;72:2628-2634.
26. Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis Source. J Infect Dis 2002;186:1463-1468.
27. Ranjbar S, Ly N, Thim S, Reynes JM, Goldfeld AE. Mycobacterium tuberculosis recall antigens suppress HIV-1 replication in anergic donor cells via CD8(+) T cell expansion and increased IL-10 levels. J. Immnnol 2004;172:1953-1959.
28. Forlsch D, Rollinghoff M, Stenger S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol 2000;165:978-987.
29. Matsuda T, Nakamura T, Nakao K, Arai T, Katsuki M, Heike T, Yokota T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 1999;18:4261-4269.
30. Takeda K, Clauscn BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49.
31. Lee CK, Rax R, Gimeno R, Gertner R, Wistinghausen B, Takeshita K, DePinho RA, Levy DE. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependenl differentiation. Immunity 2002;17:63-72.
32. Geijtenbeek TBH, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GCF, Middel J, Cornelissen ILMHA, Notlel HSLM, Kewal-Ramani VN, Littman DR. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587-597.
33. Berrier A, Siu G, Calame K. Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocyfic cells. J. Immunol 1998;161:2267-2275.
34. Komuro I, Yokota Y, Yasuda S, Iwamoto A, Akagawa KS. CSF-induced and HIV-1-mediated distinct regulation of Hck and C/UBPbeta represent a heterogeneous susceptibility of monoeyle-derived macrophages Io M-tropic HIV-1 infection. J. Exp Med 2003;198:443-453.
35. Condos R, Raju B, Canova A, Zhao B, Weiden M, Rom WN, Pine R. Recombinant inlerferon-gamma stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients. Infect Immun 2003;71:2058-2064.
36. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a CIEBP family. EMBO J 1990;9:1897-1906.